Deubiquitinases in cancer
- PMID: 25972356
- PMCID: PMC4536986
- DOI: 10.18632/oncotarget.3671
Deubiquitinases in cancer
Abstract
Deubiquitinases are deubiquitinating enzymes (DUBs), which remove ubiquitin from proteins, thus regulating their proteasomal degradation, localization and activity. Here, we discuss DUBs as anti-cancer drug targets.
Keywords: cancer; deubiquitinases; inhibitor; ubiquitylation.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Fraile J, et al. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene. 2011;31:2373–2388. - PubMed
-
- Pickart CM. Mechanisms underlying ubiquitination. Annual review of biochemistry. 2001;70:503–533. - PubMed
-
- Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006;22:159–180. - PubMed
-
- Komander D, Clague MJ, Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nature reviews Molecular cell biology. 2009;10:550–563. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
